The High Court ruled in that case in July that one of Moderna's mRNA patents was valid and Pfizer and BioNTech's Comirnaty ...

Here, doctors explain which COVID-19 vaccine is better when comparing Moderna, Pfizer, and Novovax. Plus, the efficacy of ...

The two companies brought legal action over a repeated sequence in the messenger RNA (mRNA) used in CureVac's patents in life ...

Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its ...

An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic ...

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.